Literature DB >> 16323430

Differential effects on CLL cell survival exerted by different microenvironmental elements.

P Ghia1, P Circosta, C Scielzo, A Vallario, A Camporeale, L Granziero, F Caligaris-Cappio.   

Abstract

Selected microenvironmental stimuli confer to leukemic cells a growth advantage and an extended survival. We aimed at dissecting the differential support provided by the different cellular components of the microenvironment where CLL cells accumulate. To this end we cultured purified CLL cells in vitro in the presence or absence of different accessory cells (stromal cells, autologous T lymphocytes) and/or soluble molecules (IL-4, sCD40L) and assessed the leukemic cell response in terms of cell viability and chemoattracting capacity. The results indicate that both T lymphocytes and stromal cells are involved in sustaining the survival of leukemic B cells, but indicate that their support is different in terms of time of onset and duration. T cells have a short-term support activity while stromal cells provide long-term support.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16323430     DOI: 10.1007/3-540-29933-5_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  14 in total

1.  The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.

Authors:  Mohammad Luqman; Sha Klabunde; Karen Lin; Georgios V Georgakis; Anu Cherukuri; Jocelyn Holash; Cheryl Goldbeck; Xiaomei Xu; Edward E Kadel; Sang Hoon Lee; Sharon Lea Aukerman; Bahija Jallal; Natasha Aziz; Wen-Kai Weng; William Wierda; Susan O'Brien; Anas Younes
Journal:  Blood       Date:  2008-05-22       Impact factor: 22.113

2.  CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.

Authors:  Mercedes Borge; Paula Romina Nannini; Jeremías Gastón Galletti; Pablo Elías Morande; Julio Sánchez Avalos; Raimundo Fernando Bezares; Mirta Giordano; Romina Gamberale
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

3.  Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia.

Authors:  Xiao-Jie Yan; Igor Dozmorov; Wentian Li; Sophia Yancopoulos; Cristina Sison; Michael Centola; Preetesh Jain; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  Blood       Date:  2011-09-12       Impact factor: 22.113

Review 4.  In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing.

Authors:  Eva Hoferkova; Sona Kadakova; Marek Mraz
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

5.  Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners.

Authors:  Byeongho Jung; Gerardo Ferrer; Pui Yan Chiu; Rukhsana Aslam; Anita Ng; Florencia Palacios; Michael Wysota; Martina Cardillo; Jonathan E Kolitz; Steven L Allen; Jacqueline C Barrientos; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  JCI Insight       Date:  2022-06-22

Review 6.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

7.  Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.

Authors:  Morgan O'Hayre; Catherina L Salanga; Thomas J Kipps; Davorka Messmer; Pieter C Dorrestein; Tracy M Handel
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

8.  Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA.

Authors:  Basile Stamatopoulos; Benjamin Haibe-Kains; Carole Equeter; Nathalie Meuleman; Anne Sorée; Cécile De Bruyn; Delphine Hanosset; Dominique Bron; Philippe Martiat; Laurence Lagneaux
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

Review 9.  Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.

Authors:  Sarah E M Herman; Adrian Wiestner
Journal:  Semin Oncol       Date:  2016-02-08       Impact factor: 4.929

10.  Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNT/PCP, Flt-3L/Flt-3 and CXCL9/CXCR3 as Regulators of Cell Proliferation, Survival and Migration.

Authors:  Daruka Mahadevan; James Choi; Laurence Cooke; Bram Simons; Christopher Riley; Thomas Klinkhammer; Rohit Sud; Sirisha Maddipoti; Sean Hehn; Harinder Garewal; Catherine Spier
Journal:  Hum Genomics Proteomics       Date:  2009-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.